Association analysis of genetic polymorphisms in the CDC2 gene with late-onset Alzheimer disease

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 2, 2007, Pages 126-132

  Liang, Xueying ^a   Schnetz Boutaud, Nathalie ^a   Bartlett, Jackie ^a   Anderson, Brent M ^a   Gwirtsman, Harry ^b   Schmechel, Don ^c   Carney, Regina ^c   Gilbert, John R ^c   Pericak Vance, Margaret A ^c   Haines, Jonathan L ^a,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; CDC2; Cell division cycle 2; Genetics, complex disorders; Single nucleotide polymorphisms

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CDC2 GENE; CONTROLLED STUDY; FAMILY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SEX; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CDC2 PROTEIN KINASE; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENES, CDC; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VARIATION (GENETICS);

EID: 33846205111     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097857     Document Type: Article

References (25)

1. Francis PT, Palmer AM, Snape M, Wilcock GK: The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 1999;66: 137-147.
2. Guttman R, Altman RD, Nielsen NH: Alzheimer disease. Report of the Council on Scientific Affairs. Arch Fam Med 1999;8:347-353.
3. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B: Apolipoprotein E: binding to soluble Alzheimer beta-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
4. Myers AJ, Goate AM: The genetics of late-onset Alzheimer's disease. Curr Opin Neurol 2001;14:433-440.
5. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
6. Pericak-Vance MA, Grubber J, Bailey LR, et al: Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000;35:1343-1352.
7. Myers A, Wavrant De-Vrieze F, Holmans P, et al: Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002;114:235-244.
8. Mayeux R, Lee JH, Romas SN, et al: Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet 2002;70:237-243.
9. Liang X, Schnetz-Boutaud N, Kenealy SJ, et al: Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. Mol Psychiatry 2006;11:280-285.
10. Bertram L, Blacker D, Mullin K, et al: Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000;290:2302-2303.
11. Myers A, Holmans P, Marshall H, et al: Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000;290:2304-2305.
12. Ertekin-Taner N, Graff-Radford N, Younkin LH, et al: Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000;290:2303-2304.
13. Johansson A, Hampel H, Faltraco F, et al: Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci Lett 2003;340:69-73.
14. McKhann G, Drachman G, Folstein M: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
15. Rimmler J, McDowell J, Slotterbeck BD, et al: Development of a data coordinating center (DCC): data quality control for complex disease studies. Am J Hum Genet 1998;63:A240.
16. Zaykin D, Zhivotovsky L, Weir BS: Exact tests for association between alleles at arbitrary numbers of loci. Genetica 1995;96:169-178.
17. Abecasis GR, Cookson WO: GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-183.
18. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000;67:146-154.
19. Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER: Genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol 2003;25:203-213.
20. Ott J: Analysis of Human Genetic Linkage. Baltimore, Johns Hopkins University Press, 1999.
21. Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, Boehnke M: Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol 2004;27:53-63.
22. Dupont WD, Plummer WD Jr: Power and sample size calculations. A review and computer program. Control Clin Trials 1990;11:116-128.
23. Baumann K, Mandelkow EM, Biernat J, et al: Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 1993;336:417-424.
24. Vincent I, Jicha G, Rosado M, Dickson DW: Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997;17:3588-3598.
25. Johansson A, Zetterberg H, Hampel H, et al: Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease. Dement Geriatr Cogn Disord 2005;20:367-374.